Vimarsana
Biggest News Aggregation in the World

Page 14 - Quotient Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quotient Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quotient Sciences Today - Breaking & Trending Today

UK men to test hormone-free male contraceptive pill - Vimarsana News

UK men to test hormone-free male contraceptive pill

Scientists said that if the pill can be used widely it will transform contraception.

British men first in the world to try new hormone-free male contraceptive pill - Vimarsana News

British men first in the world to try new hormone-free male contraceptive pill

Unlike the female pill, a new male equivalent, YCT-529, is hormone-free and prevents sperm production by blocking access to vitamin A. If the tests prove successful, scientists hope the responsibility for contraception could be shared between the sexes.

Source: sky.com
'A trillion in each of us': Flagship-backed Quotient takes on somatic genomics - Vimarsana News

'A trillion in each of us': Flagship-backed Quotient takes on somatic genomics

Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens, co-founder and president of Quotient Therapeutics Inc., a company that emerged from stealth this week, backed by two years of platform development and a $50 million investment from Flagship Pioneering.

Global Gastroretentive Drug Delivery Systems Outsourcing - Vimarsana News

Global Gastroretentive Drug Delivery Systems Outsourcing

Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC - Vimarsana News

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...